Researchers from the Rubin Institute for Advanced Orthopaedics at Sinai Hospital of Baltimore conducted the study demonstrating that the use of TissueLink’s saline-enhanced radiofrequency technology was associated with a significant reduction in intra-operative and post-operative blood loss and a significant reduction in the need for blood transfusions in patients undergoing total hip replacement surgery.
Separate results from a randomized, prospective study using TissueLink’s bipolar sealing technology in patients undergoing total knee replacement surgery were generated by scientists from St Vincent Hospital in Indianapolis, Indiana. The authors reported that the use of TissueLink’s technology was associated with a significant reduction in blood loss, as measured by hemoglobin loss, compared to patients managed via a conventional approach.
“Undergoing total knee replacement exposes patients to the potential for major perioperative blood loss,” said Dr Philip Ireland, an orthopaedic surgeon from St Vincent’s Hospital in Carmel and co-investigator for the study. “Minimizing blood loss with TissueLink’s bipolar sealing technology may reduce the risk of transfusions and improves patient outcomes following surgery.”